About us

Syncona, is a leading FTSE 250 healthcare company focused on founding, building and funding a portfolio of global leaders in life sciences

We were founded in 2012 by The Wellcome Trust to found companies around innovative life science and invest in them over the long-term to build global, sustainable businesses.

Our vision is to build a sustainable, diverse portfolio of 15 - 20 companies focused on delivering transformational treatments to patients, through which we are seeking to deliver strong risk-adjusted returns for shareholders.

We take a long-term view, underpinned by a strategic capital base which enables us to maintain significant ownership positions in our companies and provides us with control and flexibility over the management of our portfolio. We believe we have the team, track record and skill-set to capture the superior returns available from commercialising exceptional science.